2024
Substance use patterns, quantities, and associated risk factors in women with polysubstance misuse
Fogelman N, Tate M, Wemm S, Sullivan L, Hart R, Vacey E, Fox H, Sinha R. Substance use patterns, quantities, and associated risk factors in women with polysubstance misuse. Addiction Biology 2024, 29: 10.1111/adb.13390. PMID: 38619491, PMCID: PMC11017971, DOI: 10.1111/adb.13390.Peer-Reviewed Original ResearchConceptsPolysubstance useDepressive symptomsSubstance use patternsDrug cravingRisk factorsPatterns of polysubstance useSingle substance useAssociated with polysubstance usePlacebo-controlled studyHigher cravingGuanfacine treatmentCross-sectional observational studyPolysubstance use patternsCraving managementLife eventsCravingPolysubstance misuseSubstance useOpioid amountsPain ratingsStress/traumaObservational studyAnxietyPainPolysubstance
2023
A pilot, randomized, placebo-controlled study of mindfulness meditation in treating insomnia in multiple sclerosis
Guarnaccia J, Njike V, Dutton A, Ayettey R, Treu J, Comerford B, Sinha R. A pilot, randomized, placebo-controlled study of mindfulness meditation in treating insomnia in multiple sclerosis. BMC Neurology 2023, 23: 263. PMID: 37434109, PMCID: PMC10334613, DOI: 10.1186/s12883-023-03309-0.Peer-Reviewed Original ResearchConceptsInsomnia Severity IndexSleep efficiencyQuality of lifeMultiple sclerosisSleep qualitySelf-reported sleep qualityMultiple Sclerosis QualityPlacebo-controlled studyPrimary outcome measureParallel group designConclusionThis pilot studySelf-reported outcomesChronic insomniaOutcome measuresStudy interventionLife InventoryI cohortQuality rating scaleInsomniaCognitive functionWeekly sessionsBeneficial effectsLife measurementsRating ScaleMental health